genotype-phenotype analysis Sema4, AdventHealth Collaborate on Analysis-Driven Personalized Health Program The partners will structure and curate genomic and longitudinal clinical data for AI-based analysis using Sema4's Centrellis cloud-based health intelligence platform. Seven Bridges, ZS Partner for Multiomics Analytics in Drug Development The partners hope to provide scalable "one-stop" analytics convenience to ZS's pharmaceutical clients. Korean Rare Disease Diagnostics Firm 3billion Looks to 2022 IPO, Expansion Into Drug Discovery Premium Fresh off a $13 million round of venture capital, the company said it sees global potential in analyzing hereditary conditions. Datavant, Cerebral Palsy Research Network Seek Genetic Clues to CP Barrow Neurological Institute and the University of Utah will use Datavant technology to link known mutations to phenotypes in the disease registry. Genomics Plc Closes $30M Funding Round The British genome analysis company will use the proceeds to continue its growth in the field of genomics-driven preventive care. Feb 24, 2021 Syapse Plans Deeper Dive Into Large Health Systems for Data-Driven Cancer Insights Premium Feb 19, 2021 NRGene Looks to Royalty-Based Partnerships in Wake of IPO Premium Jan 26, 2021 BC Platforms, Finnish Researchers, Japan's Riken Partner on COVID-19 Risk Assessment Dec 10, 2020 All of Us Program Returns First Genetic Results; Health-Related Finding to Follow in Late 2021 Premium Nov 13, 2020 With $50M in New Funding, Congenica Works on Platform Upgrades for Clinical Applications Premium Oct 27, 2020 WUSTL, PercayAI to Seek COVID-19 Treatments Via AI, Deep Learning Aug 18, 2020 CHOP Automates Phenotyping of Epilepsy Patients, Heralding 'EMR Genomics' Era Premium Jul 22, 2020 Risk-Assessment Phase of eMERGE Looks to Diversify Polygenic Risk Scoring Premium May 28, 2020 Mendelian Disease Diagnosis Gets Boost From Automated Software That Scans Full-Text Articles Premium May 12, 2020 EMBL-EBI COVID-19 Data Portal to Serve as European Data Hub for Coronavirus Research Premium Feb 28, 2020 NHGRI Precision Health Research Program Using Reverse Phenotyping to Better Understand Genomics Premium Feb 19, 2020 Nigerian Research Consortium Begins Collecting Genetic, Clinical Data From 100K Subjects Premium Jan 29, 2020 Nference Poised for Growth Following Mayo Clinic Investment, Partnership Premium Jan 8, 2020 Nference Raises $60M in Series B Investment Round Sep 26, 2019 Vanderbilt Leans on BioVU as it Builds 'All of Us' Database, Infrastructure Premium Sep 16, 2019 Interoperability Network Helps Children's Hospitals Aggregate Genotype-Phenotype Data Premium May 16, 2019 Indivumed, Gnosis Team on AI for Multi-Omics Cancer Research May 14, 2019 BGI Genomics, Pryzm Health Partner on 'Precision Public Health' Mar 20, 2019 Gene42, Care4Rare Launch Cloud-Based Platform for Rare Disease Research Premium Mar 5, 2019 IQvia Launches Genomics Technology Platform Premium Load More Breaking News Singular Genomics Systems Reports No Revenues, Increased Net Loss for Q2 Burning Rock Biotech, Impact Therapeutics Partner on CDx for PARP Inhibitor Senaparib Gene Editing Analysis Firm SeQure Dx Closes $17.5M Series A Funding Round Resolve Biosciences, Zeiss Partner to Enhance Spatial Biology Imaging Tech EliTechGroup Obtains CE Mark for Saliva Use With SARS-CoV-2 Test Waters Q2 Revenues Up 31 Percent The Scan And Back The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database. Lacks Family Hires Attorney A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports. For the Unknown The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona. PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.